140 related articles for article (PubMed ID: 20869715)
1. The anti-atherogenic aspect of metformin treatment in insulin resistant women with the polycystic ovary syndrome: role of the newly established pro-inflammatory adipokine Acute-phase Serum Amyloid A; evidence of an adipose tissue-monocyte axis.
Tan BK; Adya R; Shan X; Aghilla M; Lehnert H; Keay SD; Randeva HS
Atherosclerosis; 2011 Jun; 216(2):402-8. PubMed ID: 20869715
[TBL] [Abstract][Full Text] [Related]
2. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
[TBL] [Abstract][Full Text] [Related]
3. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.
Tan BK; Adya R; Chen J; Farhatullah S; Heutling D; Mitchell D; Lehnert H; Randeva HS
Cardiovasc Res; 2009 Aug; 83(3):566-74. PubMed ID: 19414528
[TBL] [Abstract][Full Text] [Related]
4. Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome.
Tan BK; Chen J; Hu J; Amar O; Mattu HS; Adya R; Patel V; Ramanjaneya M; Lehnert H; Randeva HS
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1891-900. PubMed ID: 24152681
[TBL] [Abstract][Full Text] [Related]
5. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose.
Tan BK; Adya R; Farhatullah S; Lewandowski KC; O'Hare P; Lehnert H; Randeva HS
Diabetes; 2008 Apr; 57(4):801-8. PubMed ID: 18174521
[TBL] [Abstract][Full Text] [Related]
6. Phosphoprotein enriched in diabetes gene product (Ped/pea-15) is increased in omental adipose tissue of women with the polycystic ovary syndrome: ex vivo regulation of ped/pea-15 by glucose, insulin and metformin.
Tan BK; Chen J; Adya R; Randeva HS
Diabetes Obes Metab; 2011 Feb; 13(2):181-4. PubMed ID: 21199270
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
[TBL] [Abstract][Full Text] [Related]
8. Insulin and metformin regulate circulating and adipose tissue chemerin.
Tan BK; Chen J; Farhatullah S; Adya R; Kaur J; Heutling D; Lewandowski KC; O'Hare JP; Lehnert H; Randeva HS
Diabetes; 2009 Sep; 58(9):1971-7. PubMed ID: 19502420
[TBL] [Abstract][Full Text] [Related]
9. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
10. Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome.
Tao T; Li S; Zhao A; Zhang Y; Liu W
Eur J Endocrinol; 2012 Nov; 167(5):705-13. PubMed ID: 22945299
[TBL] [Abstract][Full Text] [Related]
11. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
Diamanti-Kandarakis E; Paterakis T; Alexandraki K; Piperi C; Aessopos A; Katsikis I; Katsilambros N; Kreatsas G; Panidis D
Hum Reprod; 2006 Jun; 21(6):1426-31. PubMed ID: 16497699
[TBL] [Abstract][Full Text] [Related]
12. Treatment of polycystic ovary syndrome (PCOS) with metformin ameliorates insulin resistance in parallel with the decrease of serum interleukin-6 concentrations.
Luque-Ramírez M; Escobar-Morreale HF
Horm Metab Res; 2010 Oct; 42(11):815-20. PubMed ID: 20730705
[TBL] [Abstract][Full Text] [Related]
13. Impact of treatment with metformin on adipokines in patients with polycystic ovary syndrome.
Tarkun I; Dikmen E; Cetinarslan B; Cantürk Z
Eur Cytokine Netw; 2010 Dec; 21(4):272-7. PubMed ID: 21126943
[TBL] [Abstract][Full Text] [Related]
14. Metformin increases the novel adipokine adipolin/CTRP12: role of the AMPK pathway.
Tan BK; Chen J; Adya R; Ramanjaneya M; Patel V; Randeva HS
J Endocrinol; 2013 Nov; 219(2):101-8. PubMed ID: 23946431
[TBL] [Abstract][Full Text] [Related]
15. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
Hu W; Qiao J; Yang Y; Wang L; Li R
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):53-6. PubMed ID: 21530057
[TBL] [Abstract][Full Text] [Related]
16. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
[TBL] [Abstract][Full Text] [Related]
18. Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids.
Tan BK; Chen J; Lehnert H; Kennedy R; Randeva HS
J Clin Endocrinol Metab; 2007 Jul; 92(7):2764-72. PubMed ID: 17456573
[TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome influences the level of serum amyloid A and activity of phospholipid transfer protein in HDL₂ and HDL₃.
Gidwani S; Phelan N; McGill J; McGowan A; O'Connor A; Young IS; Gibney J; McEneny J
Hum Reprod; 2014 Jul; 29(7):1518-25. PubMed ID: 24842896
[TBL] [Abstract][Full Text] [Related]
20. Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin.
Tan BK; Chen J; Digby JE; Keay SD; Kennedy CR; Randeva HS
J Clin Endocrinol Metab; 2006 Dec; 91(12):5022-8. PubMed ID: 17003086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]